Bene fi t of Vasodilating b-Blockers in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention : Nationwide Multicenter Cohort Study
暂无分享,去创建一个
M. Jeong | Y. Ahn | Young Jo Kim | M. Cho | C. Kim | S. Chae | I. Seong | J. Chae | K. Park | Hyo‐Soo Kim | Hyun-Jae Kang | Jung‐Kyu Han | Han-Mo Yang | B. Koo | I. Chae | Jaehoon Chung | J. Chung | J. Han
[1] K. Alexander,et al. Clinical outcomes with β-blockers for myocardial infarction: a meta-analysis of randomized trials. , 2014, The American journal of medicine.
[2] J. Cockcroft,et al. Central blood pressure: current evidence and clinical importance. , 2014, European heart journal.
[3] M. Jeong,et al. Association of beta-blocker therapy at discharge with clinical outcomes in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. , 2014, JACC. Cardiovascular interventions.
[4] Luc Trudeau,et al. Central blood pressure as an index of antihypertensive control: determinants and potential value. , 2014, The Canadian journal of cardiology.
[5] Jackson T. Wright,et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). , 2014, JAMA.
[6] Dong Bin Kim,et al. Benefit of β-blocker treatment for patients with acute myocardial infarction and preserved systolic function after percutaneous coronary intervention , 2014, Heart.
[7] P. Deedwania. Hypertension, Dyslipidemia, and Insulin Resistance in Patients With Diabetes Mellitus or the Cardiometabolic Syndrome: Benefits of Vasodilating β‐Blockers , 2011, Journal of clinical hypertension.
[8] T. Münzel,et al. Nebivolol: the somewhat-different beta-adrenergic receptor blocker. , 2009, Journal of the American College of Cardiology.
[9] M. Jeong,et al. Triple Versus Dual Antiplatelet Therapy in Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention , 2009, Circulation.
[10] R. Collins,et al. Early intravenous then oral metoprolol in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.
[11] H. Dargie,et al. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial , 2001, The Lancet.
[12] S. Jacob,et al. Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? , 1998, American journal of hypertension.
[13] Deepak L. Bhatt,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Circulation.